Voloridge Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.6M | Sell |
|
|||||
|
2025
Q2 | $13.9M | Sell |
|
|||||
|
2025
Q1 | $20.6M | Sell |
|
|||||
|
2024
Q4 | $28.9M | Buy |
|
|||||
|
2024
Q3 | $14.9M | Buy |
|
|||||
|
2024
Q2 | $1.49M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $10.4M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $42.9M | Sell |
|
|||||
|
2022
Q2 | $54.7M | Buy |
|
|||||
|
2022
Q1 | $38.9M | Buy |
|
|||||
|
2021
Q4 | $21.1M | Buy |
|
|||||
|
2021
Q3 | $380K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $2.56M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $4.24M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $733K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $885K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $616K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1.79M | Buy |
|